Literature DB >> 20442730

NASH: Thiazolidinediones for NASH--one pill doesn't fix everything.

Brent A Neuschwander-Tetri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20442730     DOI： 10.1038/nrgastro.2010.50

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  12 in total

Review 1.  Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASH.

Authors:  Brent A Neuschwander-Tetri
Journal:  Curr Gastroenterol Rep       Date:  2010-02

Review 2.  PPARgamma-mediated insulin sensitization: the importance of fat versus muscle.

Authors:  Ulrich Kintscher; Ronald E Law
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-02       Impact factor: 4.310

3.  Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.

Authors:  Manal F Abdelmalek; Ayako Suzuki; Cynthia Guy; Aynur Unalp-Arida; Ryan Colvin; Richard J Johnson; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

4.  Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.

Authors:  Vlad Ratziu; Fréderic Charlotte; Carole Bernhardt; Philippe Giral; Marine Halbron; Gilles Lenaour; Agnès Hartmann-Heurtier; Eric Bruckert; Thierry Poynard
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

Review 5.  The epidemiology of nonalcoholic fatty liver disease in adults.

Authors:  Jeanne M Clark
Journal:  J Clin Gastroenterol       Date:  2006-03       Impact factor: 3.062

6.  Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.

Authors:  Amalia Gastaldelli; Stephen A Harrison; Renata Belfort-Aguilar; Lou Jean Hardies; Bogdan Balas; Steven Schenker; Kenneth Cusi
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

7.  Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.

Authors:  Laura H Tetri; Metin Basaranoglu; Elizabeth M Brunt; Lisa M Yerian; Brent A Neuschwander-Tetri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-04       Impact factor: 4.052

8.  Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease.

Authors:  Kate S Collison; Zakia Maqbool; Soad M Saleh; Angela Inglis; Nadine J Makhoul; Razan Bakheet; Mohammed Al-Johi; Rana Al-Rabiah; Marya Z Zaidi; Futwan A Al-Mohanna
Journal:  J Lipid Res       Date:  2008-11-11       Impact factor: 5.922

9.  PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization.

Authors:  Shigeki Sugii; Peter Olson; Dorothy D Sears; Maziyar Saberi; Annette R Atkins; Grant D Barish; Suk-Hyun Hong; Glenda L Castro; Yun-Qiang Yin; Michael C Nelson; Gene Hsiao; David R Greaves; Michael Downes; Ruth T Yu; Jerrold M Olefsky; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

10.  Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects.

Authors:  S Kechagias; A Ernersson; O Dahlqvist; P Lundberg; T Lindström; F H Nystrom
Journal:  Gut       Date:  2008-02-14       Impact factor: 23.059
View more
  7 in total

1.  Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.

Authors:  Xianjun Luo; Honggui Li; Linqiang Ma; Jing Zhou; Xin Guo; Shih-Lung Woo; Ya Pei; Linda R Knight; Michael Deveau; Yanming Chen; Xiaoxian Qian; Xiaoqiu Xiao; Qifu Li; Xiangbai Chen; Yuqing Huo; Kelly McDaniel; Heather Francis; Shannon Glaser; Fanyin Meng; Gianfranco Alpini; Chaodong Wu
Journal:  Gastroenterology       Date:  2018-09-10       Impact factor: 22.682

Review 2.  Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease.

Authors:  Kristina Blaslov; Tomislav Bulum; Karin Zibar; Lea Duvnjak
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

3.  Mice lacking adenosine 2A receptor reveal increased severity of MCD-induced NASH.

Authors:  Jing Zhou; Honggui Li; Yuli Cai; Linqiang Ma; Destiny Mathews; Bangchao Lu; Bilian Zhu; Yanming Chen; Xiaoxian Qian; Xiaoqiu Xiao; Qifu Li; Shaodong Guo; Yuqing Huo; Liang Zhao; Yanan Tian; Qingsheng Li; Chaodong Wu
Journal:  J Endocrinol       Date:  2019-09-01       Impact factor: 4.286

4.  Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice.

Authors:  Xin Guo; Honggui Li; Hang Xu; Vera Halim; Weiyu Zhang; Huan Wang; Kuok Teong Ong; Shih-Lung Woo; Rosemary L Walzem; Douglas G Mashek; Hui Dong; Fuer Lu; Lai Wei; Yuqing Huo; Chaodong Wu
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

5.  Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.

Authors:  Shih-Lung Woo; Hang Xu; Honggui Li; Yan Zhao; Xiang Hu; Jiajia Zhao; Xin Guo; Ting Guo; Rachel Botchlett; Ting Qi; Ya Pei; Juan Zheng; Yiming Xu; Xiaofei An; Lulu Chen; Lili Chen; Qifu Li; Xiaoqiu Xiao; Yuqing Huo; Chaodong Wu
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

6.  Glucagon-like Peptide-1 Improves Fatty Liver and Enhances Thermogenesis in Brown Adipose Tissue via Inhibiting BMP4-Related Signaling Pathway in High-Fat-Diet-Induced Obese Mice.

Authors:  Xingchun Wang; Bingwei Ma; Jiaqi Chen; Hui You; Chunjun Sheng; Peng Yang; Shen Qu
Journal:  Int J Endocrinol       Date:  2021-04-26       Impact factor: 3.257

7.  Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease.

Authors:  Xingchun Wang; Bangfeng Zhao; Hang Sun; Hui You; Shen Qu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-22       Impact factor: 6.055
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.